Acquisition by Van Houte Hans of 120000 shares of Nurix Therapeutics subject to Rule 16b-3

NRIX
 Stock
  

USD 12.64  0.68  5.11%   

Nurix investor sentiment overview provides quick insight into current market opportunities from investing in Nurix Therapeutics. The current market sentiment together Nurix Therapeutics' historical and current headlines can help investors to time the market. Many technical investors use Nurix Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Additionally, see Nurix Therapeutics Hype Analysis, Nurix Therapeutics Correlation and Nurix Therapeutics Performance.
  
Nurix Therapeutics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Nurix daily returns and investor perception about the current pice of Nurix Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Filed transaction by Nurix Therapeutics Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Nurix insider trading alert for grant of employee stock option (right to buy) by Van Houte Hans, Chief Financial Officer, on 10th of August 2022. This event was filed by Nurix Therapeutics Inc with SEC on 2022-08-10. Statement of changes in beneficial ownership - SEC Form 4

Nurix Therapeutics Investor Sentiment by Other News Outlets

Nurix Therapeutics Fundamental Analysis

We analyze Nurix Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nurix Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nurix Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price to Sales

Price to Sales Comparative Analysis

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Peers

Trending Equities

XOM  4.04   
0%
89.0%
BFC  2.31   
0%
51.0%
FRHC  1.67   
0%
37.0%
ARMK  1.52   
0%
33.0%
STX  0.75   
0%
16.0%
QYLD  0.12   
0%
2.0%
HZNSF  0.00   
0%
0%
POW  0.10   
2.0%
0%
VST  0.22   
4.0%
0%
VLUE  0.27   
6.0%
0%
MOTO  0.45   
9.0%
0%
VGLT  1.10   
24.0%
0%
TWST  1.91   
42.0%
0%
MBIN  1.95   
43.0%
0%
NHTC  2.03   
45.0%
0%
SBNY  2.03   
45.0%
0%
MHNC  3.19   
70.0%
0%
AMN  3.24   
71.0%
0%
BNPQF  3.25   
72.0%
0%
FMURX  4.50   
100.0%
0%
Additionally, see Nurix Therapeutics Hype Analysis, Nurix Therapeutics Correlation and Nurix Therapeutics Performance. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for analysis

When running Nurix Therapeutics price analysis, check to measure Nurix Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix Therapeutics is operating at the current time. Most of Nurix Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nurix Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nurix Therapeutics' price. Additionally, you may evaluate how the addition of Nurix Therapeutics to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Nurix Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nurix Therapeutics. If investors know Nurix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nurix Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nurix Therapeutics is measured differently than its book value, which is the value of Nurix that is recorded on the company's balance sheet. Investors also form their own opinion of Nurix Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Nurix Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nurix Therapeutics' market value can be influenced by many factors that don't directly affect Nurix Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nurix Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Nurix Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nurix Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.